Results 11 to 20 of about 9,625,606 (401)
Evans syndrome and Graves' Disease: An unusual presentation – A case report
Apollo Medicine, 2022 Introduction: Evans syndrome (ES), an infrequently encountered haematological condition, is characterized by coombs-positive autoimmune hemolytic anaemia (AIHA) in association with immune thrombocytopenia (ITP). The association of ES with Graves' disease
Amtoj Singh Lamba +3 more
doaj +1 more source
SARS-CoV-2 plays a pivotal role in inducing hyperthyroidism of Graves’ disease
Endocrine, 2021 Coronavirus disease 2019 (COVID-19) advances to affect every part of the globe and remains a challenge to the human race. Severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) was shown to affect many organs and organ systems including the thyroid
A. K. Murugan, A. Alzahrani
semanticscholar +1 more source
, 2021 Graves’ disease is an autoimmune disease characterized by hyperthyroidism due to circulating autoantibodies. Graves’ disease was originally known as “exophthalmic goiter” but is now named after Sir Robert Graves, an Irish doctor who first described the condition in 1835.
Prazeres, de Oliveira, Paula Aragão +4 more
+8 more sources
Frontiers in Public Health, 2021 Background: Mounting evidence has revealed the interrelationship between thyroid and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to explain the thyroid dysfunction and autoimmune thyroid disorders observed after coronavirus disease 2019 (
D. Lui +5 more
semanticscholar +1 more source
The Role of the Microbiota in Graves’ Disease and Graves’ Orbitopathy
Frontiers in Cellular and Infection Microbiology, 2021 Graves‘ disease (GD) is a clinical syndrome with an enlarged and overactive thyroid gland, an accelerated heart rate, Graves’ orbitopathy (GO), and pretibial myxedema (PTM). GO is the most common extrathyroidal complication of GD. GD/GO has a significant
Jueyu Hou +3 more
semanticscholar +1 more source
Graves’ disease and Graves’ orbitopathy following COVID-19
Journal of Endocrinological Investigation, 2021 Upon genetic predisposition, Graves’ disease (GD) is believed to be triggered by nongenetic factors, including infections [1]. The immune system plays a role in Coronavirus disease 2019 (COVID-19), being involved in its clinical course and outcome [2 ...
G. Lanzolla, C. Marcocci, M. Marinò
semanticscholar +1 more source
European Journal of Case Reports in Internal Medicine, 2021 Graves' disease is the most frequent cause of hyperthyroidism in young women. This auto-immune disease is due to the production of class 1 IgG stimulating the TSH receptor.
Guillaume Pierman +2 more
semanticscholar +1 more source
Pretibial myxedema: Paradoxical manifestation of thyroid dermopathy after I-131 ablation therapy
Journal of Medical Sciences, 2020 Pretibial myxedema (PM) is an unusual extrathyroidal manifestation of Graves' disease (GD), which affects approximately 1%–5% of the patients. In addition, PM usually occurs in the hyperthyroid state of GD, and the high level of thyroid autoantibodies is
Bing-Sian Lin +2 more
doaj +1 more source
The Indonesian Journal of Gastroenterology, Hepatology and Digestive Endoscopy, 2022 Graves' disease is an autoimmune thyroid disease with several characteristic symptoms and signs. Graves' ophthalmopathy, an inflammatory disease in the orbital area, is the main extrathyroid manifestation of Graves' disease.
Herry Krisnata Ginting, Soebagijo Adi
doaj +1 more source
Journal of Endocrinological Investigation, 2020 To the Editor Since the outbreak of the SARS-CoV-2 pandemic, there have been many reports of autoimmune diseases triggered by or related to COVID-19 such as Guillain–Barre’s syndrome, autoimmune haemolytic anaemia, autoimmune thrombotic thrombocytopenic ...
M. Mateu-Salat, E. Urgell, A. Chico
semanticscholar +1 more source